MU

Meera Unnithan

Director Director DIN 08144226
DIN 08144226 First appointment Aug 2018 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Aug 2018
Shareholding value Locked Premium profile

About Meera Unnithan

Data last updated:

Meera Unnithan has 8 years in corporate governance. Formerly with 1 company, such as Mercel Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08144226
Primary Designation Director
First Appointment 01 Aug 2018
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Mercel Pharma Private Limited U51100KL2010PTC026396
Director01 Aug 20182010Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mercel Pharma Private Limited
Premium access

Shareholding and investment profile for Meera Unnithan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meera Unnithan

Meera Unnithan has 8 years in corporate governance. Formerly with 1 company, such as Mercel Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Meera Unnithan is associated with 0 companies as a director.

Meera Unnithan has expertise in General Business.

Meera Unnithan has 8 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available